NEWSROOM
Discover all the actions carried out by Jeito and all the partnerships that we set up day after day for the well-being of patients and medical progress.
In the headlines
Jeito Capital announces significant participation in $187 million Series A financing for Callio Therapeutics to advance innovative multi-payload ADC programs designed to maximize therapeutic benefit for cancer patients
Callio Therapeutics is a biotechnology company developing multi-payload ADCs with technology and programs exclusively in-licensed from Singapore-based Hummingbird Bioscience. Investment will contribute to achieve clinical proof-of-concept for Callio’s HER-2-targeted...
Download our White Paper
We are pleased to share with you our White Paper, which offers a deep dive into the evolving biopharma landscape and highlights the key trends shaping its future.
Find all our press releases
Jeito Capital becomes key investor in Alentis Therapeutics as part of $67 million Series B financing round
Jeito Capital selects Alentis Therapeutics as its fifth investment since launching the fund...
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide
Jeito selects Pulmocide as its fourth investment since launching the fund Pulmocide is a...
First Year-in-Review: Jeito Capital confirms strength of its investment model and 2021 ambitions with more deals and significant capital
The investment fund confirms the strength of its investment model in medical innovation, closing...
Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders
Jeito’s third international investment in H2 2020, with deep and rapidly accelerating pipeline...
Sanofi selects Jeito Capital as its first investment into a private French-based fund
Paris, France, 13 November 2020 – Jeito Capital (“Jeito”), a rapidly emerging independent investor...
Jeito Capital becomes major investor in SparingVision as part of €44.5 Million financing
Jeito Capital has selected SparingVision as its first French investment following the fund I...
Face to face
Meet Jeito
12-15
January
All day long
JPM Healthcare Conference 2026
Jeito will be present at the 44th JPM Healthcare Conference 2026, renowned as the largest and most influential healthcare investment symposium, attracting global industry leaders, Biotech companies, and members of the investment community, in San Francisco.